Clofarabine-fludarabine-busulfan in HCT for pediatric leukemia: an effective, low toxicity, TBI-free conditioning regimen
A. Birgitta Versluijs(NHS Blood and Transplant), Marc Bierings(University Medical Center Utrecht), Arjan C. Lankester(Leiden University Medical Center), Dorine Bresters(Willem-Alexander Kinderziekenhuis), Wouter J.W. Kollen(Princess Máxima Center), Stefan Nierkens(Utrecht University), Jaap Jan Boelens(Wilhelmina Children's Hospital), Coco de Koning(University Medical Center Utrecht), Caroline A. Lindemans(University Medical Center Utrecht)
Cited by 20
Related Papers
Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
|Nature Immunology|2016|727
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554